Page last updated: 2024-08-22

yttrium and (dtpa-phe(1))-octreotide

yttrium has been researched along with (dtpa-phe(1))-octreotide in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buchsbaum, DJ; Chaudhuri, TR; Lin, CY; Rogers, BE; Zinn, KR1

Other Studies

1 other study(ies) available for yttrium and (dtpa-phe(1))-octreotide

ArticleYear
Targeted radiotherapy with [(90)Y]-SMT 487 in mice bearing human nonsmall cell lung tumor xenografts induced to express human somatostatin receptor subtype 2 with an adenoviral vector.
    Cancer, 2002, Feb-15, Volume: 94, Issue:4 Suppl

    Topics: Adenoviridae; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Disease Models, Animal; Drug Delivery Systems; Genetic Vectors; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Octreotide; Pentetic Acid; Radioimmunodetection; Radiotherapy; Receptors, Somatostatin; Somatostatin; Treatment Outcome; Tumor Cells, Cultured; Xenograft Model Antitumor Assays; Yttrium

2002